2013白血病·淋巴瘤Requires access

Highlights of myelodysplastic syndromes in the 18th congress of the European Hematology Association

Dan Xu, Bing Xu

Open publisher page 0 citations

Abstract

Highlights of myelodysplastic syndromes(MDS)in the 18th congress of the European Hematology Association(EHA)were reviewed.Some new discoveries about the spectrum of gene mutations,prognosis and treatment of MDS patients were reported. Key words: Myelodysplastic syndromes; European Hematology Association annual meeting

About this research paper

What this paper is about

Highlights of myelodysplastic syndromes(MDS)in the 18th congress of the European Hematology Association(EHA)were reviewed.Some new discoveries about the spectrum of gene mutations,prognosis and treatment of MDS patients were reported. Key words: Myelodysplastic syndromes; European Hematology Association annual meeting

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Highlights of myelodysplastic syndromes(MDS)in the 18th congress of the European Hematology Association(EHA)were reviewed.Some new discoveries about the spectrum of gene mutations,prognosis and treatment of MDS patients were reported. Key words: Myelodysplastic syndromes; European Hematology Association annual meeting

Key concepts: Hematology, Myelodysplastic syndromes, Internal medicine, Medicine, Oncology, Family medicine, Bone marrow

Related papers

Back to paper searchBrowse research topicsOriginal source
Highlights of myelodysplastic syndromes in the 18th congress of the European Hematology Association — Research Paper | ScholarLens